Provided by Tiger Trade Technology Pte. Ltd.

Iterum Therapeutics Plc

0.3020
+0.01685.89%
Volume:218.59K
Turnover:66.20K
Market Cap:15.94M
PE:-0.41
High:0.3158
Open:0.2955
Low:0.2900
Close:0.2852
52wk High:1.60
52wk Low:0.2600
Shares:52.79M
Float Shares:52.38M
Volume Ratio:0.41
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7366
EPS(LYR):-1.2576
ROE:-555.68%
ROA:-53.28%
PB:-2.16
PE(LYR):-0.24

Loading ...

Company Profile

Company Name:
Iterum Therapeutics Plc
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
9
Office Location:
3 Dublin Landings,North Wall Quay,Dublin,Co. Dublin,Ireland
Zip Code:
D01 C4E0
Fax:
- -
Introduction:
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Directors

Name
Position
Corey N. Fishman
Director, President and Chief Executive Officer
David G. Kelly
Director and Chairman
Beth P. Hecht
Director
Joseph J. Whalen
Director
Michael W. Dunne
Director

Shareholders

Name
Position
Corey N. Fishman
Director, President and Chief Executive Officer
Judith M. Matthews
Chief Financial Officer
Christine R. Coyne
Chief Commercial Officer